RNASEL 1623A>C variant is associated with the risk of prostate cancer in African descendants

Journal of Cellular Biochemistry
Jian WangWei Zhang

Abstract

Association between ribonuclease L (RNASEL) gene 1623A>C polymorphism and prostate cancer (PCa) susceptibility has been assessed in large quantities of studies but with controversial conclusions. We undertook a pooled analysis containing 7397 PCa cases and 6088 control subjects to assess the correlation between RNASEL 1623A>C polymorphism and PCa risk. Moreover, we used enzyme-linked immunosorbent assay to test the serum RNASEL expression among patients enrolled in our centers and in-silico tools were also utilized. The overall results of our analysis indicated a positive relationship between 1623A>C variant and PCa risk (allelic contrast, odds ratio [OR] = 1.07; 95% confidence interval [CI] = 1.02-1.12; Pheterogeneity  = 0.575; CC vs AA, OR = 1.14; 95% CI = 1.03-1.26; Pheterogeneity  = 0.217; CC + CA vs AA, OR = 1.10; 95% CI = 1.01-1.19; Pheterogeneity  = 0.303; and CC vs CA + AA, OR = 1.08; 95% CI = 1.00-1.17; Pheterogeneity  = 0.298). In ethnicity subgroup analysis, similar results were especially indicated in African descendants. In addition, serum RNASEL levels in PCa cases with CC + CA genotypes were higher than those with AA genotypes. Our present study showed evidence that RNASEL 1623A>C polymorphism is related to PCa r...Continue Reading

References

Apr 10, 2002·American Journal of Human Genetics·Annika RökmanJohanna Schleutker
May 22, 2002·American Journal of Human Genetics·Liang WangStephen N Thibodeau
Jul 12, 2002·Statistics in Medicine·Julian P T Higgins, Simon G Thompson
Nov 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Fredrik WiklundHenrik Grönberg
Jul 15, 2005·JAMA : the Journal of the American Medical Association·Nima SharifiWilliam L Dahut
Mar 16, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Avi Orr-UrtregerHaim Matzkin
Oct 6, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Huihua Li, Bee Choo Tai
Jul 14, 2007·Urologia Internationalis·Cezary CybulskiJan Lubiński
Aug 8, 2007·Cytokine & Growth Factor Reviews·Robert H Silverman
Oct 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Stacie J ShookRobin J Leach
Jan 15, 2008·The Prostate·Patrick R SheaRobert E Ferrell
Aug 5, 2008·Current Opinion in Pharmacology·Yu ChenHoward I Scher
Sep 2, 2008·Expert Review of Anticancer Therapy·Mary-Ellen Taplin
Jan 22, 2009·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·B MelladoP Gascón
Jan 21, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Joke BeutenRobin J Leach
Jun 26, 2010·Carcinogenesis·Mara S MeyerLorelei A Mucci
Jul 9, 2010·CA: a Cancer Journal for Clinicians·Ahmedin JemalElizabeth Ward
Nov 16, 2011·Prostate Cancer and Prostatic Diseases·M J Alvarez-CuberoJ M Cozar
Nov 15, 2013·Journal of Cellular and Molecular Medicine·Ignacio F San FranciscoAlejandro S Godoy
Aug 8, 2015·Experimental & Molecular Medicine·Maria Jesus Alvarez-CuberoJose Manuel Cozar
Mar 4, 2017·International Journal of Molecular Sciences·Shubham DayalKrishnamurthy Malathi

❮ Previous
Next ❯

Citations

Oct 21, 2020·Cancers·Maddison ArcherNatasha Kyprianou

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.